idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
14.06.2016 13:17

New plant engineering method could help fill demand for crucial malaria drug

Dipl. Ing. agr. Ursula Ross-Stitt Büro für Öffentlichkeitsarbeit
Max-Planck-Institut für Molekulare Pflanzenphysiologie

    A new and inexpensive technique for mass-producing the main ingredient in the most effective treatment for malaria, artemisinin, could help meet global demands for the drug, according to a study to be published in the journal eLife.

    Artemisinin is produced in low yields by a herb called Artemisia annua (A. annua), otherwise known as sweet wormwood. Researchers from the Max Planck Institute of Molecular Plant Physiology have now discovered a new way to produce artemisinic acid, the molecule from which artemisinin is derived, in high yields. Their method involves transferring its metabolic pathway – the series of biochemical steps involved in its production – from A. annua into tobacco, a high-biomass crop.

    “Malaria is a devastating tropical disease that kills almost half a million people every year,” says contributing author Ralph Bock, Director of the Department for Organelle Biology, Biotechnology and Molecular Ecophysiology.

    “For the foreseeable future, artemisinin will be the most powerful weapon in the battle against malaria but, due to its extraction from low-yielding plants, it is currently too expensive to be widely accessible to patients in poorer countries. Producing artemisinic acid in a crop such as tobacco, which yields large amounts of leafy biomass, could provide a sustainable and inexpensive source of the drug, making it more readily available for those who need it most.”

    The team has called this approach to producing more artemisinic acid COSTREL (“combinatorial supertransformation of transplastomic recipient lines”). The first step in their process was to transfer the genes of the artemisinic acid pathway’s core set of enzymes into the chloroplast genome of tobacco plants, generating what are known as transplastomic plants.

    The team then used their best transplastomic tobacco plant line to introduce an additional set of genes into its nuclear genome, generating the COSTREL lines. These remaining genes encode factors that increase the synthesis, or generation, of the acid in ways that are still largely unknown.

    “While the artemisinic acid pathway in A. annua is confined to the glandular hairs on the plant, leading to low yields of artemisinin, our COSTREL tobacco lines produce it in their chloroplasts and therefore the whole leaf,” says lead author and postdoctoral researcher Paulina Fuentes.

    “We generated over 600 engineered tobacco plant lines that harbour different combinations of these additional genes, and analysed them in terms of the amounts of artemisinic compounds they acquired. We could then identify those that generated unprecedented levels of 120 milligrams per kilogram of artemisinic acid in their leaves, which can be readily converted into artemisinin through simple chemical reactions.”

    Although further increases in these production levels will be needed if global demand for artemisinin is to be met, the study lays the foundation for much cheaper production of this life-saving therapy in a high-biomass crop, in contrast to a single medicinal plant.

    It also provides a new tool for engineering many other complex pathways, with the potential to increase production of other essential therapeutic ingredients.

    Reference

    The paper ‘A new synthetic biology approach allows transfer of an entire metabolic pathway from a medicinal plant to a biomass crop’ can be freely accessed online at http://dx.doi.org/10.7554/eLife.13664. Contents, including text, figures, and data, are free to reuse under a CC BY 4.0 license.
    Media contacts

    Emily Packer, eLife
    e.packer@elifesciences.org
    01223 855373

    Ulrike Glaubitz, Max Planck Institute of Molecular Plant Physiology
    glaubitz@mpimp-golm.mpg.de
    +49 331 567 8275


    Weitere Informationen:

    http://www.mpimp-golm.mpg.de/2069723/rbock-malaria-drug-in-tobacco


    Bilder

    A new and inexpensive technique for mass-producing medical drugs.
    A new and inexpensive technique for mass-producing medical drugs.


    Merkmale dieser Pressemitteilung:
    Journalisten, Lehrer/Schüler, Studierende, Wissenschaftler, jedermann
    Biologie, Tier / Land / Forst
    überregional
    Buntes aus der Wissenschaft, Forschungsergebnisse
    Englisch


     

    A new and inexpensive technique for mass-producing medical drugs.


    Zum Download

    x

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).